Sundrug Co.,Ltd.

Tokyo Stock Exchange 9989.T

Sundrug Co.,Ltd. EBITDA Margin for the year ending March 31, 2024: 7.52%

Sundrug Co.,Ltd. EBITDA Margin is 7.52% for the year ending March 31, 2024, a 4.85% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Sundrug Co.,Ltd. EBITDA Margin for the year ending March 31, 2023 was 7.17%, a 5.12% change year over year.
Sundrug Co.,Ltd. EBITDA Margin for the year ending March 31, 2022 was 6.82%, a -5.94% change year over year.
Sundrug Co.,Ltd. EBITDA Margin for the year ending March 31, 2021 was 7.25%, a -0.35% change year over year.
Sundrug Co.,Ltd. EBITDA Margin for the year ending March 31, 2020 was 7.28%, a -1.55% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

Tokyo Stock Exchange: 9989.T

Sundrug Co.,Ltd.

CEO	Mr. Hiroshi Sadakata
IPO Date	Jan. 4, 2001
Location	Japan
Headquarters	1-38-1, Wakamatsucho
Employees	6,662
Sector	Health Care
Industries Drugstores & Retail Pharmacies Discount Retailers Retail & Wholesale

Description

Sundrug Co.,Ltd. operates and manages drug stores and dispensing pharmacies in Japan. It also operates discount stores that offers food, cosmetics, home appliances, clothing, car supplies, sports and goods, alcoholic beverages, and pharmaceutical products, as well as fresh food, kerosene, etc. The company was founded in 1957 and is headquartered in Fuchu, Japan.

Key trends

Past 5 years